Cardiome Pharma Corporation (CRME)

Add to Watchlists Create an Alert
1.98 -0.04  -1.98%   NASDAQ May 22, 5:00PM BATS Real time Currency in USD

Cardiome Pharma Corporation Cash from Financing Quarterly:

-6.93M for Dec. 31, 2012
View Full Chart

Cardiome Pharma Corporation Cash from Financing Quarterly Chart

    Cardiome Pharma Corporation Historical Cash from Financing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 -6.93M
    Sept. 30, 2012 0.00
    June 30, 2012 0.00
    March 31, 2012 25.00M
    Dec. 31, 2011 0.00
    Sept. 30, 2011 0.00
    June 30, 2011 0.00
    March 31, 2011 0.358M
    Dec. 31, 2010 0.00
    Sept. 30, 2010 0.715M
    June 30, 2010 1.509M
    March 31, 2010 25.14M
    Dec. 31, 2009 -20.85M
    Sept. 30, 2009 0.819M
    June 30, 2009 0.276M
    March 31, 2009 0.00
    Dec. 31, 2008 -3.326M
    Sept. 30, 2008 24.01M
    June 30, 2008 0.106M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Aug. 31, 2003 Go Pro
    May 31, 2003 Go Pro
    Feb. 28, 2003 Go Pro
    Nov. 30, 2002 Go Pro
    Aug. 31, 2002 Go Pro
    May 31, 2002 Go Pro
    Feb. 28, 2002 Go Pro
    Nov. 30, 2001 Go Pro
    Aug. 31, 2001 Go Pro
    May 31, 2001 Go Pro
    Feb. 28, 2001 Go Pro
    Nov. 30, 2000 Go Pro
    Aug. 31, 2000 Go Pro
    May 31, 2000 Go Pro

    About Cash From Financing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
    Learn More

    Get data for

    CRME Cash from Financing Quarterly Benchmarks

    Companies
    Merrimack Pharmaceuticals 44.61M
    Chemocentryx 0.51M
    QLT -9.318M

    CRME Cash from Financing Quarterly Rankings

    Overall 59th percentile
    3221 of 8005
    Sector 31st percentile
    468 of 686 in Healthcare
    Industry 23rd percentile
    190 of 248 in Biotechnology

    CRME Cash from Financing Quarterly Range, Past 5 Years

    Minimum -20.85M Dec 2009
    Maximum 25.14M Mar 2010
    Average 2.464M